Cause if they spent 19M to gain Billions worth of all encompassing IP(NR2F6) and TWO mRNA human trial ready drugs… then that number is actually damn Impressive.
Furthermore, the only damaging debt here to shareholders is the Convertible debt type… and as the 8k clearly indicates: All done. Buh bye!